https://charts.traderzeitung.de/phases/US75062E1064 string(1414) "{"isin":"US75062E1064","name":"Rafael Holdings Inc","stock_id_xnas":null,"stock_id_xnys":10019599,"generated_at":"2026-09-24 01:36:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.97,"close_at":"2026-09-21 21:56:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.01,"close_at":"2026-09-22 21:57:00","complete":true,"perf_pct":2.0305},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.02,"close_at":"2026-09-23 21:58:00","complete":true,"perf_pct":0.4975},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":2.038,"close_at":"2026-09-23 22:00:00","complete":false,"perf_pct":0.8911}]}]}"

Rafael Holdings Aktie News & Nachrichten

[WKN: A2JDMF | Symbol: RFL]

Realtimekurs

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Rafael Holdings gefunden werden.

Rafael Holdings Nachrichtenticker öffnen

MT Newswires 10.06.2026 13:55 Uhr

Rafael schließt letzten Patientenbesuch in Studie zu Trappsol Cyclo zur Behandlung der Niemann-Pick-Krankheit Typ C ab

07:54 AM EDT, 06/10/2026 (MT Newswires) -- Rafael (RFL) sagte Mittwoch, dass der letzte Patient einen 96-wöchigen Studienbesuch in der zulassungsrelev